Moreover, ERα signaling blockade or depletion by tamoxifen or fulvestrant evoked the upregulation of programmed death-ligand 1 (PD-L1) in multiple ER + BC cell lines, contributing to the cytotoxic T cell evasion of BC cells [81]. Here, ESR1 is linked to breast cancer.